α2-Adrenoceptor Antagonists Reverse the 5-HT2 Receptor Antagonist Suppression of Head-Twitch Behavior in Mice

[1]  Kinzo Matsumoto,et al.  Hyperactivity of central noradrenergic and CRF systems is involved in social isolation-induced decrease in pentobarbital sleep , 1995, Brain Research.

[2]  O. Kemmotsu,et al.  Pharmacological characterization of α 2-adrenoceptor regulated serotonin release in the rat hippocampus , 1995, Neuroscience Letters.

[3]  J. Kehne,et al.  The role of 5-HT2A receptors in antipsychotic activity. , 1995, Life sciences.

[4]  T. Sharp,et al.  Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: Microdialysis studies in the awake and anaesthetized rat , 1994, Neuropharmacology.

[5]  M. Gobbi,et al.  Further Studies on α2‐Adrenoceptor Subtypes Involved in the Modulation of [3H]Noradrenaline and [3H]5‐Hydroxytryptamine Release from Rat Brain Cortex Synaptosomes , 1993, The Journal of pharmacy and pharmacology.

[6]  S. Dursun,et al.  The effects of α2‐adrenoceptor antagonists on the inhibition of 1‐(2,5‐dimethoxy‐4‐iodophenyl)‐2‐aminopropane (DOI)‐induced head shakes by 5‐HT1A receptor agonists in the mouse , 1993, British journal of pharmacology.

[7]  R. Glennon.  Do classical hallucinogens act as 5-HT2 agonists or antagonists? , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[8]  L. Singh,et al.  Involvement of the locus coeruleus in the potentiation of the quipazine-induced head-twitch response by diazepam and beta-adrenoceptor agonists , 1986, Neuropharmacology.

[9]  R. Glennon,et al.  Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. , 1984, Life sciences.

[10]  K. O'Shaughnessy,et al.  Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone , 1983, Neuropharmacology.

[11]  J. Brown,et al.  Effects on the 5-hydroxytryptamine-induced head-twitch of drugs with selective actions on alpha1 and alpha2-adrenoceptors , 1982, Neuropharmacology.

[12]  J. Leysen,et al.  [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. , 1982, Molecular pharmacology.

[13]  S. Snyder,et al.  Two distinct central serotonin receptors with different physiological functions. , 1981, Science.

[14]  J. Vetulani,et al.  Antagonism of clonidine to shaking behavior in morphine abstinence syndrome and to head twitches produced by serotonergic agents in the rat. , 1978, Polish journal of pharmacology and pharmacy.

[15]  A. Barnett,et al.  Quipazine-induced head-twitch in mice , 1977, Pharmacology Biochemistry and Behavior.

[16]  S. Corne,et al.  A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. , 1963, British journal of pharmacology and chemotherapy.

[17]  T. Haley,et al.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. , 1957, British journal of pharmacology and chemotherapy.